Eric Kelsic (Dyno)

Roche turns to a Har­vard up­start out of George Church’s lab to con­struct AAV 2.0 mod­el vec­tors — a key part of build­ing the gene ther­a­py pipeline

For a gene ther­a­py tech up­start that launched out of stealth mode just 5 months ago with big goals and not a tremen­dous amount …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.